Cargando…
FRI442 Ongoing Clomiphene Treatment For Men With Hypogonadotropic Hypogonadism
Disclosure: S.R. Smith: None. Context: Male hypogonadism is becoming recognized with increasing frequency. Testosterone products remain the only approved medical therapy, although highly problematic in men with hypogonadotropic hypogonadism because of inconvenient routes of administration, high cost...
Autor principal: | Smith, Stephen Ross |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554922/ http://dx.doi.org/10.1210/jendso/bvad114.1631 |
Ejemplares similares
-
FRI430 A Case Of Elevated Sex Hormone-binding Globulin Secondary To Variegate Porphyria In A Patient With Hypogonadotropic Hypogonadism
por: Law, Jocelyn, et al.
Publicado: (2023) -
Contribution of Copy Number Variation in Idiopathic Hypogonadotropic Hypogonadism
por: Stamou*, Maria, et al.
Publicado: (2021) -
ODP609 Optimizing Sexual Function and Libido in Men with Androgen Deficiency due to Hypogonadotropic Hypogonadism
por: Comite, Florence, et al.
Publicado: (2022) -
Safety and Efficacy of Clomiphene Citrate in the Treatment of Secondary Hypogonadism. A Retrospective Study
por: Garcia-Touza, Mariana
Publicado: (2021) -
Induction of spermatogenesis in men with hypogonadotropic hypogonadism
por: Morris, Guy C., et al.
Publicado: (2021)